Successful results of early nucleos(t)ide analogue treatment for liver transplantation candidates with severe acute hepatitis B infection

Hepatitis B

(2023) Wen-Juei Jeng et al.   LANCET

Outcomes Analyses of Pediatric Acute Liver Failure Subjects Listed for Liver Transplantation

(2022) Sakil S. Kulkarni et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Complementary Roles of Cadaveric and Living Donor Liver Transplantation in Acute Liver Failure

(2021) İlgin Özden et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Use of intravenous N-acetylcysteine in acute severe hepatitis due to severe dengue infection: a case series

(2021) D. M. D. I. B. Dissanayake et al.   BMC INFECTIOUS DISEASES

Treatment and Prevention of Acute Hepatitis B Virus

(2021) Simone E. Dekker et al.   Clinics in Liver Disease

Retrospective Analysis of the Clinical Efficacy of N-Acetylcysteine in the Treatment of Hepatitis B Virus Related Acute-on-Chronic Liver Failure

(2021) Meng-Lan Wang et al.   Frontiers in Medicine

Why are there so many liver transplants from living donors in Asia and so few in Europe and the US?

(2021) Mohamed Rela et al.   JOURNAL OF HEPATOLOGY

Live donor liver transplantation for acute liver failure - Donor safety and recipient outcome

(2019) Viniyendra Pamecha et al.   LIVER TRANSPLANTATION

Drug repurposing of N-acetyl cysteine as antiviral against dengue virus infection

(2019) Gopinathan Pillai Sreekanth et al.   ANTIVIRAL RESEARCH

Acute liver failure

(2019) R Todd Stravitz et al.   LANCET

Early Combination Therapy with Corticosteroid and Nucleoside Analogue Induces Rapid Resolution of Inflammation in Acute Liver Failure due to Transient Hepatitis B Virus Infection

(2018) Keiichi Fujiwara et al.   INTERNAL MEDICINE

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

(2017) Pietro Lampertico et al.   JOURNAL OF HEPATOLOGY

Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines

(2017) Fehmi Tabak et al.   Turkish Journal of Gastroenterology

Treatment with lamivudine and entecavir in severe acute hepatitis B

(2016) O Sandulescu et al.   Indian Journal of Medical Microbiology

Treatment of fulminant acute Hepatitis B with nucles(t)id analogues is safe and does not lead to secondary chronification of Hepatitis B

(2016) C. Jochum et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

(2015) S. K. Sarin et al.   Hepatology International

Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT)

(2014) R. Bruno et al.   INFECTION

Treatment of severe, nonfulminant acute hepatitis B with lamivudinevsplacebo: a prospective randomized double-blinded multicentre trial

(2013) J. Wiegand et al.   JOURNAL OF VIRAL HEPATITIS

Use of Nucleoside (Tide) Analogues in Patients with Hepatitis B-Related Acute Liver Failure

(2011) Doan Y. Dao et al.   DIGESTIVE DISEASES AND SCIENCES

Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?

(2011) Hans L. Tillmann et al.   LIVER INTERNATIONAL

The Study of Efficacy of Lamivudine in Patients with Severe Acute Hepatitis B

(2009) Jian-Wu Yu et al.   DIGESTIVE DISEASES AND SCIENCES